B. Riley Adjusts Price Target on Neuronetics to $6 From $5, Keeps Buy Rating

On November 6, 2026, investment firm B. Riley updated its outlook on Neuronetics, Inc. by raising the price target to $6 from the previous $5. The firm maintained its Buy rating on the company's shares. This adjustment follows the company's recent third-quarter 2026 earnings report and guidance reaffirmation.